Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed with results

Key Signals

5 with results83% success

Data Visualizations

Phase Distribution

6Total
P 2 (3)
P 3 (3)

Trial Status

Completed5
Withdrawn1
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (7)

Research Network

Activity Timeline